Rafic Beydoun

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Surgical Site Infection

Glycemic Control

Neuroendocrine Tumors

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Mohammed H Uddin, Sahar F Bannoura, Yousef Mzannar, Ibrahim Hanna Azar, Eliza Wright Beal, Miguel Tobon, Steve H Kim, Rafic Beydoun, Erkan Baloglu, William Senapedis, Bassel F El-Rayes, Philip A Philip, Ramzi M Mohammad, Anthony Frank Shields, Mohammad Najeeb Al-Hallak, Asfar S Azmi
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers. Molecular cancer therapeutics (2023)
Gabriel B Mpilla, Mohammed H Uddin, Mohammed N Al-Hallak, Amro Aboukameel, Yiwei Li, Steve H Kim, Rafic Beydoun, Gregory Dyson, Erkan Baloglu, William T Senapedis, Yosef Landesman, Kay-Uwe Wagner, Nerissa T Viola, Bassel F El-Rayes, Philip A Philip, Ramzi M Mohammad, Asfar S Azmi
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus. Molecular cancer therapeutics 20 (10) (2021)